(Q53404726)
Statements
Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells. (English)
1 reference
Thiesing JT
1 reference
Ohno-Jones S
1 reference
Kolibaba KS
1 reference
Druker BJ
1 reference
1 November 2000
1 reference
1 reference
96
1 reference
3195-3199
1 reference
9
1 reference
Identifiers
1 reference